Abstract Fibropapillomatosis (FP) - tumour-associated chelonid alphaherpesvirus 5 (ChHV5; Scutavirus chelonidalpha5) - is a disease that affect marine turtles around the world, and characterized by ...the formation of cutaneous tumours that can appear anywhere on the body. We carried out a thorough literature search (from 1990 to 2024) in the feeding sites of North-western Mexico, a region that hosts important habitats for feeding, development, and reproduction for five of the seven existing sea turtle species. We found 18 reports recording a total of 32 cases of FP and/or ChHV5/Scutavirus chelonidalpha5 in coastal and insular areas of North-western Mexico. Baja California Sur resulted with the highest number of cases (75%). While the first case of ChHV5/Scutavirus chelonidalpha5 infection was reported in 2004, the presence of FP tumours was reported in 2014 and became more frequent between 2019 and 2024. The affected species were black, Chelonia mydas (50%), olive ridley, Lepidochelys olivacea (46.8%) and loggerhead turtles, Caretta caretta (3.2%). Tumours occurred mainly in anterior flippers (46.1%) and neck (22.5%), and most had a nodular and verrucous appearance with a rough surface. In the study region, there is a potential sign of the emergence of the ChHV5/Scutavirus chelonidalpha5 infections and FP disease during the last 20 years, with a rapid increase during the last 10 years. As long as infections by ChHV5/Scutavirus chelonidalpha5 and the prevalence of the FP disease may be potentially influenced by anthropogenic activities, a One Health approach is needed to understand and improve sea turtles’ health.
In order to determine the sex of Chelonia mydas individuals found within one of the principal foraging areas of the Gulf of California during any given stage of ontogeny, 529 individuals were sampled ...in Bahía de los Ángeles from 1995–2012, and their morphometric data were collected. A principal component analysis (PCA) was performed for the morphometric variables, and two principal components were obtained that unambiguously separated sexes and ontogenetic stages. The first component was defined by straight carapace length (SCL), curve carapace length (CCL), plastron length (PL) and carapace depth (CD), while the second factor was represented by total tail length (TTL). Allometric models were fitted with the most important variables determined by the PCA. The model PL = αSCLβ was able to distinguish between adults and immature individuals. For adult organisms, the model that best separated males from females was TTL = αSCLβ. Adult females had SCL values of 66–96.7 cm and TTL values of 16.3–25 cm, while adult males had SCL values of 66.4–12.5 cm and TTL values > 25 cm. As the organisms were considered immature only if SCL < 77.3, we were able to determine the TTL values for immature individuals by using elemental mathematics and solving for SCL in the equation TTL = αSCLβ for each group (i.e. adult females, adult males and immatures). So, considering the mathematical approach and acknowledging the lack of background information, immature individuals may be considered potential females if the TTL value is between 7.04–17.8 cm and potential males if the TTL value > 17.8 cm.
The storage lesions and the irradiation of blood cellular components for medical procedures in blood banks are events that may induce nanochanges in the membrane of red blood cells (RBCs). ...Alterations, such as the formation of pores and vesicles, reduce flexibility and compromise the overall erythrocyte integrity. This review discusses the alterations on erythrocytic lipid membrane bilayer through their characterization by confocal scanning microscopy, Raman, scanning electron microscopy, and atomic force microscopy techniques. The interrelated experimental results may address and shed light on the correlation of biomechanical and biochemical transformations induced in the membrane and cytoskeleton of stored and gamma-irradiated RBC. To highlight the main advantages of combining these experimental techniques simultaneously or sequentially, we discuss how those outcomes observed at micro- and nanoscale cell levels are useful as biomarkers of cell aging and storage damage.
Abstract Background There has been debate over whether the existing World Health Organization (WHO) criteria accurately represent the severity of maternal near misses. Objective This study assessed ...the diagnostic accuracy of two WHO clinical and laboratory organ dysfunction markers for determining the best cutoff values in a Latin American setting. Methods A prospective multicenter cohort study was conducted in five Latin American countries. Patients with severe maternal complications were followed up from admission to discharge. Organ dysfunction was determined using clinical and laboratory data, and participants were classified according to severe maternal outcomes. This study compares the diagnostic criteria of Latin American Centre for Perinatology, Network for Adverse Maternal Outcomes (CLAP/NAMO) to WHO standards. Results Of the 698 women studied, 15.2% had severe maternal outcomes. Most measured variables showed significant differences between individuals with and without severe outcomes (all P ‐values <0.05). Alternative cutoff values suggested by CLAP/NAMOs include pH ≤7.40, lactate ≥2.3 mmol/L, respiratory rate ≥ 24 bpm, oxygen saturation ≤ 96%, PaO 2 /FiO 2 ≤ 342 mmHg, platelet count ≤189 × 10 9 × mm 3 , serum creatinine ≥0.8 mg/dL, and total bilirubin ≥0.67 mg/dL. No significant differences were found when comparing the diagnostic performance of the CLAP/NAMO criteria to that of the WHO standards. Conclusion The CLAP/NAMO values were comparable to the WHO maternal near‐miss criteria, indicating that the WHO standards might not be superior in this population. These findings suggest that maternal near‐miss thresholds can be adapted regionally, improving the identification and management of severe maternal complications in Latin America.
Synopsis The CLAP/NAMO diagnostic criteria identified and classified Latin American maternal near misses according to WHO standards, demonstrating the potential for reliable maternal health assessment.
PDF
